Cargando…

Contrast enhanced mammography in breast cancer surveillance

PURPOSE: Mammography (MG) is the standard imaging in surveillance of women with a personal history of breast cancer or DCIS (PHBC), supplemented with ultrasound. Contrast Enhanced Mammography (CEM) has higher sensitivity than MG and US. We report the performance of CEM compared with MG ± US. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elder, Kenneth, Matheson, Julia, Nickson, Carolyn, Box, Georgia, Ellis, Jennifer, Mou, Arlene, Shadbolt, Clair, Park, Allan, Tay, Jia, Rose, Allison, Mann, Gregory Bruce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175447/ https://www.ncbi.nlm.nih.gov/pubmed/36966271 http://dx.doi.org/10.1007/s10549-023-06916-0

Ejemplares similares

Is de-escalation of treatment by omission of radiotherapy associated with fear of cancer recurrence in women with early breast cancer? An exploratory study
por: Stafford, Lesley, et al.
Publicado: (2023)

Dethroning Contrast Angiography: A Place for Electroanatomic Mapping?
por: Kleiman, Neal S.
Publicado: (2022)

Electroanatomical Navigation to Minimize Contrast Medium or X-Rays During Stenting: Insights From an Experimental Model
por: Dorval, Jean-François, et al.
Publicado: (2021)

Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34(+) cells in a xenograft model
por: Rossini, Anna, et al.
Publicado: (2012)

Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
por: Bai, Bo, et al.
Publicado: (2019)

Contrast enhanced and dual energy mammography
por: Yaffe, MJ
Publicado: (2008)

Artifact reduction in contrast-enhanced mammography
por: Gennaro, Gisella, et al.
Publicado: (2022)

Contrast-Enhanced Spectral Mammography: Comparison with Conventional Mammography and Histopathology in 152 Women
por: Luczyńska, Elzbieta, et al.
Publicado: (2014)

Inhibition of Interleukin-17A, But Not Interleukin-17F, Signaling Lowers Blood Pressure, and Reduces End-Organ Inflammation in Angiotensin II–Induced Hypertension
por: Saleh, Mohamed A., et al.
Publicado: (2016)

TRAF2, an Innate Immune Sensor, Reciprocally Regulates Mitophagy and Inflammation to Maintain Cardiac Myocyte Homeostasis
por: Ma, Xiucui, et al.
Publicado: (2021)

Improved method for quantification of regional cardiac function in mice using phase-contrast MRI
por: Dall'Armellina, Erica, et al.
Publicado: (2012)

Circulating tumor cells in non-metastatic triple-negative breast cancer
por: Karhade, Mandar, et al.
Publicado: (2014)

Adult rat cortical thickness changes across age and following adolescent intermittent ethanol treatment
por: Vetreno, Ryan P., et al.
Publicado: (2016)

Toward Clinically Compatible Phase-Contrast Mammography
por: Scherer, Kai, et al.
Publicado: (2015)

Quantitative Breast Density in Contrast-Enhanced Mammography
por: Gennaro, Gisella, et al.
Publicado: (2021)

Contrast-Enhanced Mammography in the Diagnosis of Breast Angiosarcoma
por: Kacen, Maya Grisaru, et al.
Publicado: (2021)

The importance of early detection of calcifications associated with breast cancer in screening
por: Mordang, J. J., et al.
Publicado: (2017)

Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort
por: Cheng, Angela S., et al.
Publicado: (2019)

Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray
por: Parks, R. M., et al.
Publicado: (2020)

Is it Time for Trials on Preventing Immune-Mediated Myocardial Damage?
por: Peyster, Eliot G., et al.
Publicado: (2021)

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers
por: Aleskandarany, Mohammed, et al.
Publicado: (2015)

Connexin 43 is an independent predictor of patient outcome in breast cancer patients
por: Chasampalioti, Maria, et al.
Publicado: (2018)

The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer
por: El Ansari, Rokaya, et al.
Publicado: (2020)

Immune cell quantitation in normal breast tissue lobules with and without lobulitis
por: Degnim, Amy C., et al.
Publicado: (2014)

LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
por: Yan, S. Betty, et al.
Publicado: (2012)

Biological and clinical significance of PARP1 protein expression in breast cancer
por: Green, Andrew R., et al.
Publicado: (2014)

SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer
por: Alfarsi, Lutfi H., et al.
Publicado: (2021)

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy
por: Al-Subhi, Nouf, et al.
Publicado: (2018)

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers
por: Ahmad, Dena A. J., et al.
Publicado: (2016)

Phenotypic characterisation of breast cancer: the role of CDC42
por: Chrysanthou, Eleni, et al.
Publicado: (2017)

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
por: Joseph, Chitra, et al.
Publicado: (2020)

HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer
por: Green, Andrew R., et al.
Publicado: (2014)

Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells
por: Leung, Euphemia, et al.
Publicado: (2011)

The Effect of Estrogen on Intracellular Ca(2+) and Na(+) Regulation in Heart Failure
por: Firth, Jahn M., et al.
Publicado: (2020)

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
por: Muftah, Abir A., et al.
Publicado: (2017)

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
por: Aljohani, Abrar I., et al.
Publicado: (2019)

Natural history of age-related lobular involution and impact on breast cancer risk
por: Radisky, Derek C., et al.
Publicado: (2016)

Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients
por: Mirza, Sameer, et al.
Publicado: (2013)

Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution
por: Stallings-Mann, Melody L., et al.
Publicado: (2017)

Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model
por: Truitt, Rachel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mg0p980blc91u3573lr9omrgan